Clearing a Path for Broad Implementation of DCTs Posted on April 5, 2022February 7, 2025 by Hannah Faulkner Clearing a Path for Broad Implementation of DCTs
Considerations for Delivering an Investigational Product Posted on April 5, 2022February 7, 2025 by Hannah Faulkner Considerations for Delivering an Investigational Product
Advancing the Landscape: Increasing Diversity in Clinical Trials Posted on August 4, 2021February 21, 2025 by Hannah Faulkner Advancing the Landscape: Increasing Diversity in Clinical Trials
Best Practices for Designing High-Quality, Diverse COVID-19 Trials Posted on July 9, 2021February 21, 2025 by Hannah Faulkner Best Practices for Designing High-Quality, Diverse COVID-19 Trials
Best Practices for Conducting Trials during the COVID-19 Pandemic Posted on July 9, 2021February 21, 2025 by Hannah Faulkner Best Practices for Conducting Trials during the COVID-19 Pandemic
Informing the Renovations to the ICH E6 GCP Guideline for Good Clinical Practice Executive Summary Posted on July 9, 2021February 5, 2025 by Hannah Faulkner Informing the Renovations to the ICH E6 GCP Guideline for GCP Executive Summary
PEC Meeting Summary – July 2021 Posted on July 1, 2021February 6, 2025 by Hannah Faulkner PEC Meeting Summary – July 2021
Feasibility Studies Database Posted on June 30, 2021February 11, 2025 by Hannah Faulkner Feasibility Studies Database
Prioritization Tool for Sponsors and Patient Groups Posted on June 30, 2021February 7, 2025 by Hannah Faulkner Prioritization Tool for Sponsors and Patient Groups
